Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin/ezetimibe vs rosuvastatin in non-diabetic dyslipidemia
KCT0007278Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Oct 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rosuvastatin and ezetimibe in dyslipidemia and hypercholesterolemia (2 arms), sponsored by Daewoong Pharmaceutical. Primary endpoints: Change in blood glucose / hyperglycemia parameters and Change in lipid profile. Started Oct 2019; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
dyslipidemiahypercholesterolemia
Beyond the preview
Go deeper on KCT0007278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007278.